Literature DB >> 19011993

Concordant colon tumors in monozygotic twins previously treated for prostate cancer.

Arnoud Templeton1, Giancarlo Marra, Emanuele Valtorta, Karl Heinimann, Hansjakob Müller, Dieter Köberle, Silke Gillessen.   

Abstract

This report describes the quasi-simultaneous occurrence of colon cancers in monozygotic twin brothers (age 63 years) who had undergone androgen deprivation therapy for prostate cancers 4 years earlier. Concordance among male twins for both of these cancers has never been reported. Although the family history suggested possible genetic predispositions to both cancers, the twins have no evidence of the genetic alterations associated with hereditary colorectal tumors. We explore the possibility that colorectal tumorigenesis in these twins was fuelled by a combination of genetic and iatrogenic factors, in particular the androgen deprivation therapy used to treat their prostate cancers.

Entities:  

Mesh:

Year:  2008        PMID: 19011993     DOI: 10.1007/s10689-008-9222-8

Source DB:  PubMed          Journal:  Fam Cancer        ISSN: 1389-9600            Impact factor:   2.375


  23 in total

Review 1.  Unravelling the genetics of prostate cancer.

Authors:  Stephen M Edwards; Rosalind A Eeles
Journal:  Am J Med Genet C Semin Med Genet       Date:  2004-08-15       Impact factor: 3.908

2.  The Swedish Twin Registry in the third millennium: an update.

Authors:  Paul Lichtenstein; Patrick F Sullivan; Sven Cnattingius; Margaret Gatz; Sofie Johansson; Eva Carlström; Camilla Björk; Magnus Svartengren; Alicja Wolk; Lars Klareskog; Ulf de Faire; Martin Schalling; Juni Palmgren; Nancy L Pedersen
Journal:  Twin Res Hum Genet       Date:  2006-12       Impact factor: 1.587

3.  Complexities of prostate-cancer risk.

Authors:  Edward P Gelmann
Journal:  N Engl J Med       Date:  2008-01-16       Impact factor: 91.245

4.  Environmental and heritable factors in the causation of cancer--analyses of cohorts of twins from Sweden, Denmark, and Finland.

Authors:  P Lichtenstein; N V Holm; P K Verkasalo; A Iliadou; J Kaprio; M Koskenvuo; E Pukkala; A Skytthe; K Hemminki
Journal:  N Engl J Med       Date:  2000-07-13       Impact factor: 91.245

5.  Activation of beta-catenin signaling in prostate cancer by peptidyl-prolyl isomerase Pin1-mediated abrogation of the androgen receptor-beta-catenin interaction.

Authors:  Shao-Yong Chen; Gerburg Wulf; Xiao Zhen Zhou; Mark A Rubin; Kun Ping Lu; Steven P Balk
Journal:  Mol Cell Biol       Date:  2006-02       Impact factor: 4.272

6.  Effect of steroid hormones on human colorectal adenocarcinoma xenografts, of known steroid-receptor status, in nude mice.

Authors:  W S Stebbings; G P Vinson; M J Farthing; F Balkwill; R F Wood
Journal:  J Cancer Res Clin Oncol       Date:  1989       Impact factor: 4.553

7.  CHEK2 is a multiorgan cancer susceptibility gene.

Authors:  C Cybulski; B Górski; T Huzarski; B Masojć; M Mierzejewski; T Debniak; U Teodorczyk; T Byrski; J Gronwald; J Matyjasik; E Zlowocka; M Lenner; E Grabowska; K Nej; J Castaneda; K Medrek; A Szymańska; J Szymańska; G Kurzawski; J Suchy; O Oszurek; A Witek; S A Narod; J Lubiński
Journal:  Am J Hum Genet       Date:  2004-10-18       Impact factor: 11.025

Review 8.  A systematic review and meta-analysis of familial prostate cancer risk.

Authors:  L E Johns; R S Houlston
Journal:  BJU Int       Date:  2003-06       Impact factor: 5.588

Review 9.  The complex genetic epidemiology of prostate cancer.

Authors:  Daniel J Schaid
Journal:  Hum Mol Genet       Date:  2004-01-28       Impact factor: 6.150

10.  Effects of androgen manipulations on chemically induced colonic tumours and on macroscopically normal colonic mucosa in male Sprague-Dawley rats.

Authors:  J R Izbicki; S R Hamilton; G Wambach; E Harnisch; D K Wilker; G Dornschneider; B Eibl-Eibesfeldt; L Schweiberer
Journal:  Br J Cancer       Date:  1990-02       Impact factor: 7.640

View more
  2 in total

1.  Risk of colorectal cancer in men on long-term androgen deprivation therapy for prostate cancer.

Authors:  Silke Gillessen; Arnoud Templeton; Giancarlo Marra; Yong-Fang Kuo; Emanuele Valtorta; Vahakn B Shahinian
Journal:  J Natl Cancer Inst       Date:  2010-11-10       Impact factor: 13.506

2.  Risk of Second Primary Cancer among Prostate Cancer Patients in Korea: A Population-Based Cohort Study.

Authors:  Jae Young Joung; Jiwon Lim; Chang-Mo Oh; Kyu-Won Jung; Hyunsoon Cho; Sung Han Kim; Ho Kyung Seo; Weon Seo Park; Jinsoo Chung; Kang Hyun Lee; Young-Joo Won
Journal:  PLoS One       Date:  2015-10-15       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.